Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:32 PM
Ignite Modification Date:
2025-12-24 @ 5:32 PM
NCT ID:
NCT05440968
Eligibility Criteria:
Inclusion Criteria:
* Adult, aged greater than or equal to 18 years and less than or equal to 75 years.
* Understands, accepts and agrees to sign the informed consent form.
* FINDRISC greater than or equal to 12
Exclusion Criteria:
Previous diagnosis of type 1 or type 2 diabetes mellitus.
* Pregnancy or breastfeeding at the time of inclusion in the study (referred by the subject).
* History of cancer in the subject (must be in remission for 5 years).
* Known history of familiar hyperlipidemia.
* Chronic use of systemic corticosteroids (Defined as: a dose greater than 5 mg of oral prednisolone or its equivalent and/or consumption greater than one month of the same).
* Known history of hemophilia or other coagulation disorders.
* Known history of stage IV or V chronic kidney disease.
* Known history of HIV (on antiretroviral therapy).
* History of sickle cell disease
* Known history of glucose-6-phosphate dehydrogenase deficiency
* Known history of blood transfusion in the last 3 months
* Known history of erythropoietin therapy in the last 6 months
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT05440968
Study Brief:
Protocol Section:
NCT05440968